Couverture de Pharmacy Revenue Cycle Podcast

Pharmacy Revenue Cycle Podcast

Pharmacy Revenue Cycle Podcast

De : Visante Consulting
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

 Pharmacy Revenue Cycle News aims to provide you with helpful tips, resources, and emerging updates that can improve your pharmacy revenue. We have one very simple goal. We take complex and ever changing rules and regulations to bring you awareness and practical tools that can help you understand and enhance your pharmacy revenue cycle. Our website is full of resources, tools, explanations and links that can help you navigate the pharmacy revenue cycle. Each newsletter provides you with practical tips for you to put into your practice.2022 Economie Hygiène et vie saine Maladie et pathologies physiques Management Management et direction
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • The Heavy Hitters for July Quarterly Updates

      The Heavy Hitters for July Quarterly Updates
      Jul 6 2023

      July 2023 is here and time to validate another round of quarterly updates from CMS. The JZ modifier, in addition to the JW modifier, is now required to effectively bill for drug waste (JW) and to attest when no drug was discarded (JZ) for all separately payable that are single-dose or single-use containers. Additionally, we have updated the Visante Quarterly Update Tool and the C9399 Tool to help organizations validate that their system is up to date with the recent changes.

      Afficher plus Afficher moins
      5 min
    • Beat Inflation with a Part B Rebate

      Beat Inflation with a Part B Rebate
      Mar 21 2023

      As a part of the Inflation Reduction Act of 2022, CMS is requiring manufacture rebates for certain Medicare Part B drugs in which the cost has exceeded inflation. Beneficiaries out of pocket costs will be reduced to 20% of the inflation-adjusted payment described in the Act.
      Afficher plus Afficher moins
      5 min
    • Don't be "SAD"... An Alternative Way to Handle Self-Administered Drugs

      Don't be "SAD"... An Alternative Way to Handle Self-Administered Drugs
      Feb 28 2023

      Self-administered drugs (SAD) have been a long-standing controversy when administered in a hospital outpatient setting from the perspectives of a patient, frontline healthcare workers, and billing. "Why does my Tylenol cost $10 per tablet, but the 1,000-count bottle I have at home was purchased for $3?" This question is often difficult to answer and may lead to unintended operational consequences.

      Afficher plus Afficher moins
      8 min
    Aucun commentaire pour le moment